ArticleHaematologica2024

Nivolumab combined with brentuximab vedotin with or without mediastinal radiotherapy for relapsed/refractory primary mediastinal large B-cell lymphoma.

Loic Renaud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.